Abstract
Plasma vasopressin (AVP) levels are often elevated in congestive heart failure (CHF). To determine the significance of AVP in CHF, we performed clearance studies on the UM-X7.1 strain of cardiomyopathic (CM) hamsters with moderate heart failure and age-matched healthy controls. Exogenous AVP or a selective V<sub>2</sub> agonist (0.3 ng·kg<sup>–1</sup>·min<sup>–1</sup>) reduced the fractional excretion of sodium (FE<sub>Na</sub>) and water (FE<sub>H2</sub>O) by 40–46% in the control group. Although the CM hamsters exhibited a blunted physiological response to the V<sub>2</sub> agonist, their urinary cAMP levels were fivefold that of normal and reflect an altered regulation of V<sub>2</sub> receptor signalling during CHF. Additional studies also showed that infusion of a V<sub>2</sub> antagonist (0.3 ng·kg<sup>–1</sup>·min<sup>–1</sup>) produced natriuresis and diuresis in CM hamsters (FE<sub>Na</sub>: 7.9 ± 1.1 vs. 4.8 ± 0.6%, p < 0.05; FE<sub>H2</sub>O: 2.2 ± 3 vs. 1.5 ± 0.2%, p < 0.05) but did not decrease fluid reabsorption in the normal hamsters. In conclusion, the attenuated renal response to exogenous AVP in CM hamsters may be attributed to an enhanced endogenous AVP response during CHF.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
